Literature DB >> 11439093

Phosphorylation of human plasma alpha2-Heremans-Schmid glycoprotein (human fetuin) in vivo.

A C Haglund 1, B Ek, P Ek.   

Abstract

A fraction of alpha2-Heremans-Schmid (alpha2-HS) glycoprotein (human fetuin) isolated from plasma was phosphorylated at serine-120 and serine-312 as shown by MS and peptide fragment sequencing after tryptic digestion. Serine-312-containing peptides were phosphorylated to 77% as determined from relative peak heights in the mass spectrum, which together with the phosphorylation of serine-120 implies a molar degree of phosphorylation of at least 1. Approximately 20% of the circulating fetuin plasma pool was phosphorylated to approx. 1 mol of phosphate/mol of protein. The remainder did not contain phosphate, resulting in an average phosphorylation degree for the protein in plasma of approx. 0.2 mol/mol. The isolated alpha2-HS glycoprotein was a heterodimer in which the entire C-terminal part of the connecting peptide including threonine-321 was present, but traces of C-terminally trimmed connecting peptide fragments were also found. The short B-chain was O-glycosylated to approx. 40%, whereas the N-glycosylation of asparagine-138 and asparagine-158 seemed to be 100%. This finding, for the first time, that circulating human plasma fetuin is partly phosphorylated, implies that the effects of phosphorylated alpha2-HS glycoprotein on insulin signal transduction seen in different cell systems could be relevant to its physiological function in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439093      PMCID: PMC1221970          DOI: 10.1042/0264-6021:3570437

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

Review 1.  Fetuin--an old friend revisited.

Authors:  W M Brown; N R Saunders; K Møllgård; K M Dziegielewska
Journal:  Bioessays       Date:  1992-11       Impact factor: 4.345

2.  Posttranslational processing of human alpha 2-HS glycoprotein (human fetuin). Evidence for the production of a phosphorylated single-chain form by hepatoma cells.

Authors:  W Jahnen-Dechent; A Trindl; J Godovac-Zimmermann; W Müller-Esterl
Journal:  Eur J Biochem       Date:  1994-11-15

3.  Baculoviral expression of a natural inhibitor of the human insulin receptor tyrosine kinase.

Authors:  P R Srinivas; A S Goustin; G Grunberger
Journal:  Biochem Biophys Res Commun       Date:  1995-03-17       Impact factor: 3.575

4.  Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry.

Authors:  M Wilm; A Shevchenko; T Houthaeve; S Breit; L Schweigerer; T Fotsis; M Mann
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

5.  Electrophoretic and isoelectric focusing analysis of human recombinant alpha 2-HS glycoprotein produced in insect cells: analysis of the post-translational events.

Authors:  L Kalabay; S Mathur; S Bobin; P Arnaud
Journal:  Electrophoresis       Date:  1996-03       Impact factor: 3.535

6.  Effect of phosphorylated rat fetuin on the growth of hepatocytes in primary culture in the presence of human hepatocyte-growth factor. Evidence that phosphorylated fetuin is a natural modulator of hepatocyte-growth factor.

Authors:  T Ohnishi; O Nakamura; N Arakaki; Y Daikuhara
Journal:  Eur J Biochem       Date:  1997-02-01

7.  Limited proteolysis of human alpha2-HS glycoprotein/fetuin. Evidence that a chymotryptic activity can release the connecting peptide.

Authors:  P Nawratil; S Lenzen; J Kellermann; H Haupt; T Schinke; W Müller-Esterl; W Jahnen-Dechent
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

8.  Recombinant human alpha 2-HS glycoprotein inhibits insulin-stimulated mitogenic pathway without affecting metabolic signalling in Chinese hamster ovary cells overexpressing the human insulin receptor.

Authors:  P R Srinivas; D D Deutsch; S T Mathews; A S Goustin; M A Leon; G Grunberger
Journal:  Cell Signal       Date:  1996-12       Impact factor: 4.315

9.  The human hepatoma Hep3B cell line as an experimental model in the study of the long-term regulation of acute-phase proteins by cytokines.

Authors:  M Hiron; M Daveau; P Arnaud; J Bauer; J P Lebreton
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

10.  Structure of the N- and O-glycans of the A-chain of human plasma alpha 2HS-glycoprotein as deduced from the chemical compositions of the derivatives prepared by stepwise degradation with exoglycosidases.

Authors:  H Watzlawick; M T Walsh; Y Yoshioka; K Schmid; R Brossmer
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

View more
  17 in total

1.  Fetuin-A, a hepatocyte-specific protein that binds Plasmodium berghei thrombospondin-related adhesive protein: a potential role in infectivity.

Authors:  Deepa Jethwaney; Timothy Lepore; Saria Hassan; Kerrianne Mello; Radha Rangarajan; Willi Jahnen-Dechent; Dyann Wirth; Ali A Sultan
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Visceral and subcutaneous adipose tissue express and secrete functional alpha2hsglycoprotein (fetuin a) especially in obesity.

Authors:  Diego Pérez-Sotelo; Arturo Roca-Rivada; María Larrosa-García; Cecilia Castelao; Iván Baamonde; Javier Baltar; Ana Belen Crujeiras; Luisa María Seoane; Felipe F Casanueva; María Pardo
Journal:  Endocrine       Date:  2016-10-14       Impact factor: 3.633

Review 3.  Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes.

Authors:  Josiah Ochieng; Gladys Nangami; Amos Sakwe; Cierra Moye; Joel Alvarez; Diva Whalen; Portia Thomas; Philip Lammers
Journal:  Int J Mol Sci       Date:  2018-07-29       Impact factor: 5.923

Review 4.  Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.

Authors:  Kerstin Wolk; Robert Sabat
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

5.  Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A.

Authors:  Bernd Denecke; Steffen Gräber; Cora Schäfer; Alexander Heiss; Michael Wöltje; Willi Jahnen-Dechent
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

6.  Obesity and kidney disease: Beyond the hyperfiltration.

Authors:  A Mascali; O Franzese; S Nisticò; U Campia; D Lauro; C Cardillo; N Di Daniele; M Tesauro
Journal:  Int J Immunopathol Pharmacol       Date:  2016-04-04       Impact factor: 3.219

7.  Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage.

Authors:  Edward R Smith; Eric Hanssen; Lawrence P McMahon; Stephen G Holt
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

8.  Decreased expression of alpha-2-HS glycoprotein in the sera of rats treated with Eurycoma longifolia extract.

Authors:  Yeng Chen; Wai-Mei Phang; Alan K-W Mu; Choon-Keat Chan; Bin-Seng Low; Sreenivasan Sasidharan; Kit-Lam Chan
Journal:  Front Pharmacol       Date:  2015-09-23       Impact factor: 5.810

9.  Urinary proteomic and non-prefractionation quantitative phosphoproteomic analysis during pregnancy and non-pregnancy.

Authors:  Jianhua Zheng; Liguo Liu; Jin Wang; Qi Jin
Journal:  BMC Genomics       Date:  2013-11-11       Impact factor: 3.969

Review 10.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.